Impact COVID-19 on Monoclonal Antibodies Market 2021 Generated Opportunities for Growth in The Global Monoclonal Antibodies Industry

Different monoclonal antibodies with unique mechanism of actions have been approved over the past few years, which work on immune checkpoints such as CTLA-4, PD-1, and PD-L1. Manufacturers are focusing on developing drugs belonging to various classes in order to treat variety of diseases ranging from cancer to rare diseases. Monoclonal antibody coupled with chemotherapy agents is becoming a viable treatment option to treat various cancers. For instance, in 2017, the U.S. Food & Drug Administration (FDA) approved Darzalex (daratumumab) in combination with pomalidomide and dexamethasone for the treatment of patients suffering from multiple myeloma, who have received two prior therapies.

The Monoclonal Antibodies Market has accounted for US$ 143.5 billion in 2020, and is expected to reach US$ 368.8 billion by 2028, growing at a CAGR 14.4% during the forecast period 2021 to 2028.

Download PDF Sample Report @
https://www.coherentmarketinsights.com/insight/request-sample/2403

Major Market Competitors

Pfizer Inc.*
Novartis AG
Bayer AG
Sanofi S.A.
Hoffmann-La Roche AG
Eli Lilly and Co.
Merck & Co., Inc.
GlaxoSmithKline Plc.
AbbVie Inc.
Bristol-Myers Squibb
Regeneron Pharmaceuticals Inc.

Market Segmentation

By Source:

Human
Chimeric
Murine
Humanized
By Application:

Cancer
Autoimmune Disease
Hematological Disease
Infectious Disease
Others
By Distribution Channel:

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

For Customization on this Report @ https://www.coherentmarketinsights.com/insight/request-customization/2403

Frequently Asked Questions?

What will the market size be in 2028?

What are the key factors driving the European market?

What are the challenges to market growth?

Who are the key players in the market?

What are the market opportunities and threats faced by the key players?

What will be the growth rate in 2028?

Which strategies are used by top players in the Monoclonal Antibodies Market?

An Important Area of the Report

Market size for both regional as well global level for the forecast timeframe of 2021-2028

Growth factor, limitation, trend, and emerging opportunities in the market

Latest key development in medical technology

In-depth analysis of the present market scenario and future prediction of the industry

Buy This Complete A Business Report:
https://www.coherentMarketinsights.com/promo/buynow/2403

Covid-19 Impact:

The COVID-19 pandemic has exacerbated the world’s healthcare challenges. Social distancing and shutdowns have accelerated adoption of digital technologies in the healthcare sector. Our updated reports have answers to various concerns in the global Monoclonal Antibodies market caused due to the pandemic.

Contact us:
Mr. Shah
Senior Client Partner – Business Development
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
sales@coherentMarketinsights.com

About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.

This release was published on openPR.